First Results of the Risk -Adapted, MRD -Stratified GMALL Trial 08/2013 in 705 Adults with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL/LBL)
Journal title abbreviation:
Blood
Year:
2021
Journal volume:
138 Suppl 1
Print-ISSN:
0006-4971
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)